AMEX · VHAQ
Viveon Health Acquisition Corp.
$10.00$0.00 (0.0%)
Viveon Health Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 15.97% below the high.
Loading market information…
OTC · BBLNF · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Babylon Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Babylon Holdings Limited’s next earnings report is currently expected on Nov 12, 2026, with estimated earnings per share of -$5.32. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Babylon Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Babylon Holdings Limited operated as a digital healthcare company, providing comprehensive, end-to-end care solutions. These offerings included a sophisticated digital health platform, virtual consultations, in-person medical services, and subsequent post-care support, notably featuring its proprietary Babylon Cloud and various clinical services. Established in 2013, the company was headquartered in Austin, Texas. A significant event occurred on August 9, 2023, when Babylon Inc., along with an affiliate, filed a voluntary petition for Chapter 7 liquidation in the U.S. Bankruptcy Court for the District of Delaware.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:05 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.00$0.00 (0.0%)
Viveon Health Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 15.97% below the high.
$0.00-$0.00 (0.0%)
PAO Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
$0.00$0.00 (0.0%)
BZAM Ltd.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
$0.00$0.00 (0.0%)
Neurobiological Technologies, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Anthera Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
SheerVision, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
OncoVista Innovative Therapies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
$0.00$0.00 (0.0%)
Longport, Inc.: Healthcare · Medical - Devices.
